Skip to main content
AC

Aphelion Capital

Founded in 2005, Aphelion Capital invests in early- and mid-stage medical device and digital health companies focused on improving patient outcomes at equal or lower cost.

Aphelion Capital is an investment firm founded in 2005 that backs early- and mid-stage companies in medical devices, digital health and medical technology. Its mandate centres on capital-efficient businesses whose products and services improve patient outcomes at the same or lower cost to the healthcare system - a criteria set that reflects the sector's prevailing pressure on reimbursement and delivery economics. Target areas include healthcare delivery innovation alongside device and digital-health products.

The firm invests at early and mid stage through venture and strategic investment. Specific fund sizes and typical check sizes are not disclosed. Portfolio support extends beyond capital: Aphelion establishes strategic relationships intended to give companies access to resources within the healthcare ecosystem, and it frames its approach as investing in ideas, entrepreneurs and companies - backing leaders addressing practical challenges in the delivery of care.

The stated focus on the quality and efficiency of care suggests a diligence emphasis on clinical and economic outcomes rather than technology alone. Aphelion Capital maintains a website at https://www.aphelioncapital.net/.

Open jobs

No open jobs right now.